Hefei Hengxin Life Science & Technology Co Ltd Expands Investment Horizons

Hefei Hengxin Life Science and Technology Co., Ltd., a company listed on the Shenzhen Stock Exchange, has announced its strategic move to invest in the venture capital sector. The company plans to allocate CNY 10 million to participate in the equity of the Qingcheng Jinyi Fund, a venture capital fund managed by Beijing Fangyuan Jin Ding Investment Management Co., Ltd. This initiative is part of Hefei Hengxin’s broader strategy to diversify its business operations and leverage the expertise and resources of professional investment institutions.

The investment will focus on a single target, Tai Le Yuan, with the aim of achieving capital appreciation through equity investment. This move is expected to enhance Hefei Hengxin’s overall competitive strength and profitability while ensuring the stable development of its core business in manufacturing and distributing environmentally friendly paper containers, including paper cups, bowls, and lunch boxes.

Market Performance and Analyst Insights

On July 15, 2025, Hefei Hengxin experienced significant capital outflows, with net outflows amounting to CNY 41.66 million. The stock price dropped by 3.14%, and the net flow ratio was -2.09%. This activity placed the company at 5129 out of 5150 in the market ranking.

Analysts have noted that the large negative net flow indicates a substantial sell-off by major shareholders, suggesting a higher likelihood of continued selling pressure. The high turnover rate on this day further supports this view. Investment advisors recommend that investors maintain a cautious approach and manage their positions prudently in the short term.

Company Overview

Hefei Hengxin Life Science and Technology Co., Ltd. is known for its production of eco-friendly paper products, including cups, bowls, and lunch boxes, as well as plastic accessories like lids, spoons, and straws. As of July 15, 2025, the company’s closing price was CNY 56.64, with a market capitalization of approximately CNY 7.66 billion. The price-to-earnings ratio stood at 25.8084, reflecting its market valuation.

Disclaimer

The analysis provided is based on internet big data and does not represent the company’s stance or constitute investment advice. Investors are advised to be aware of investment risks.

For more detailed information, investors can refer to the official announcement available here .